# Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma

> **NCT00021359** · PHASE2 · COMPLETED · sponsor: **Fox Chase Cancer Center** · enrollment: 17 (actual)

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** isotretinoin

## Key facts

- **NCT ID:** NCT00021359
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08
- **Primary completion:** 2000-07
- **Final completion:** 2005-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2013-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00021359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00021359, "Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00021359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*